This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

MR guided radiotherapy represents one of the most promising recent technological
innovations in the field. The possibility to better visualize therapy volumes, coupled with the …

Abstract The Barcelona Clinic Liver Cancer (BCLC) system is the most commonly used
staging system for hepatocellular carcinoma (HCC) in Western countries. BCLC aims to …

The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …

Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide and the second most common oncological reason for death. Liver resection and …

Hepatocellular carcinoma is a common cancer with a poor prognosis, associated with high
economic costs and a significant burden of disease. While it is often asymptomatic in the …

Widespread commercialization of high‐energy‐density lithium–sulfur (Li–S) batteries is
difficult due to the lithium polysulfide, Li2Sn (n= 4, 6, 8), shuttle effect. Efficient …

Conventional transarterial chemoembolization (cTACE), drug-eluting beads (DEB-TACE)
and transarterial radioembolization (TARE) are alternative strategies for unresectable …

Portal vein tumor thrombus (PVTT) is one of the most common complications of
hepatocellular carcinoma (HCC), which refers to the advanced stage of HCC and indicates …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the 3 rd
leading cause of cancer death worldwide. Treatment options include surgical resection, liver …